Showing results (451-460 of 476) with videos related to
Sort By:
Pageof 48
Functional & Integrative Genomics|March 22, 2014
Antimicrobial peptides in the centipede Scolopendra subspinipes mutilansWon Gi Yoo, Joon Ha Lee, Younhee Shin, et al.Nature Communications|March 19, 2023
PCR-like performance of rapid test with permselective tunable nanotrapSeong Jun Park, Seungmin Lee, Dongtak Lee, et al.Eclinicalmedicine|April 12, 2021
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipientsPer Ljungman, Arancha Bermudez, Aaron C Logan, et al.European Journal of Haematology|November 2, 2012
Response to pretransplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromesSeung-Ah Yahng, Jae-Ho Yoon, Seung-Hwan Shin, et al.Annals of Hematology|November 20, 2012
Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcomeSi-Hyun Kim, Jae-Cheol Kwon, Su-Mi Choi, et al.The Lancet. Respiratory Medicine|April 17, 2025
Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trialMichael G Ison, Alberto Papi, Eugene Athan, et al.Annals of Internal Medicine|January 20, 2015
Combination antifungal therapy for invasive aspergillosis: a randomized trialKieren A Marr, Haran T Schlamm, Raoul Herbrecht, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2024
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV SeasonsMichael G Ison, Alberto Papi, Eugene Athan, et al.Oncotarget|February 22, 2018
Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapySeung-Hwan Shin, Byung-Sik Cho, Sung-Soo Park, et al.Annals of Hematology|June 29, 2013
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in KoreaJin Seok Kim, June-Won Cheong, Yeo-Kyeoung Kim, et al.Pageof 48